Recent News

By Category: Countermeasures

CDC partners with 104 employers for National Healthy Worksite Program

(CDC) The Centers for Disease Control and Prevention, through its partner Viridian Health Management, has identified 104 employers in eight counties across the nation that have voluntarily chosen to participate in the National Healthy Worksite Program, a new initiative aimed at reducing chronic disease and building a healthier, more productive U.S. workforce. The initiative primarily Read More »

June 11, 2013
| Filed under North America, Countermeasures, Policy & Initiatives, Public Health, and Research
Share

NIH Awards $18M to Study Deadly Secrets of Viral Pathogens

(GlobalBiodefense) In an effort to sort out why some viruses such as influenza, Ebola and West Nile are so lethal, a team of U.S. researchers plans a comprehensive effort to model how humans respond to these biological threats. The study will be led by Yoshihiro Kawaoka, a University of Wisconsin-Madison School of Veterinary Medicine professor Read More »

June 11, 2013
| Filed under North America, Agents & Toxins, Bioterrorism, Countermeasures, Public Health, and Research
Share

Vaccination Programs In Schools Could Reduce Flu Cases and Deaths

(GlobalBiodefense) Offering flu vaccines at elementary schools could expand vaccination rates and reduce costs, according to a new study reported in the scientific journal Vaccine by researchers from UC Davis Health System; the Monroe County, New York, Department of Public Health; University of Rochester Medical Center; and U.S. Centers for Disease Control and Prevention (CDC).

June 6, 2013
| Filed under North America, Agents & Toxins, Countermeasures, Policy & Initiatives, and Public Health
Share

University of Maryland School of Medicine finds gut bacteria play key role in vaccination

(EurekAlert) The bacteria that live in the human gut may play an important role in immune response to vaccines and infection by wild-type enteric organisms, according to two recent studies resulting from a collaborative effort between the University of Maryland School of Medicine Institute for Genome Sciences and the Center for Vaccine Development. The first Read More »

June 6, 2013
| Filed under North America, Agents & Toxins, Countermeasures, Public Health, and Research
Share

Duke to co-lead NIH research network on antibacterial resistance

(EurekAlert) Investigators at Duke Medicine and the University of California, San Francisco (UCSF) have been selected to oversee a nationwide research program on antibacterial resistance, which includes a focus on the growing unmet challenges associated with methicillin-resistant Staphylococcus aureus (MRSA) and E. coli. The research team will direct the allocation of a federal grant from Read More »